Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
The U.S. Food and Drug Administration announced this week that it will conduct a complete safety review of the drug, Pradaxa (dabigatran), following reports that it may cause excessive bleeding. Pradaxa is an oral direct thrombin inhibitor that is used to prevent stroke in patients suffering from nonvalvular atrial fibrillation. The FDA’s safety review announcement [...]
The consumer watchdog group, Public Citizen, this week asked the U.S. Food and Drug Administration not to approve the drug, rivaroxaban (Xarelto), for use in patients with atrial fibrillation, citing concerns over the drug’s overall safety and efficacy. The group issued a letter to the FDA, specifically addressing a recent discrepancy in opinion between an [...]
